{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:28:47Z","timestamp":1770218927407,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.eplepsyres.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T11:10:34Z","timestamp":1327835434000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model"],"prefix":"10.1016","volume":"100","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Kominek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Florek-Luszczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz A.","family":"Tchaytchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey L.","family":"Kocharov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Zolkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"A simple novel method to explore tranquilizer activity: the chimney test (in French)","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp. (Basel)"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","article-title":"Established antiepileptic drugs","volume":"6","author":"Brodie","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1014233102342","article-title":"Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats","volume":"19","author":"Cadart","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0030","first-page":"457","article-title":"Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)-3-substituted pyrrolidine-2,5-dione derivatives","volume":"65","author":"Kaminski","year":"2008","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on?","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0050","first-page":"82","article-title":"Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity","volume":"32","author":"Lange","year":"1977","journal-title":"Pharmazie"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0920-1211(99)00095-9","article-title":"The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures","volume":"38","author":"L\u00f6scher","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2008.11.049","article-title":"Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"602","author":"Luszczki","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2010.08.017","article-title":"Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenyl-succinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model","volume":"648","author":"Luszczki","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neures.2009.03.010","article-title":"N-(anilinomethyl)-p-isopropoxyphenyl-succinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model","volume":"64","author":"Luszczki","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1734-1140(10)70257-7","article-title":"Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model","volume":"62","author":"Luszczki","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2005.11.045","article-title":"2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice","volume":"531","author":"Luszczki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(03)00081-9","article-title":"Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice","volume":"75","author":"Luszczki","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0110","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0115","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1016\/j.bmc.2010.06.064","article-title":"Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins","volume":"18","author":"Obniska","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00046-8","article-title":"Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds","volume":"42","author":"Rogawski","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0125","series-title":"Molecular and Cellular Targets for Anti-epileptic Drugs","first-page":"191","article-title":"The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project","author":"Stables","year":"1997"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0135","series-title":"Antiepileptic Drugs","first-page":"36","article-title":"Discovery and preclinical development of antiepileptic drugs","author":"White","year":"2002"},{"key":"10.1016\/j.eplepsyres.2012.01.003_bib0140","first-page":"69","article-title":"Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides","volume":"42","author":"Zejc","year":"1990","journal-title":"Pol. J. Pharmacol. Pharm."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:26:17Z","timestamp":1760275577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0920121112000046"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}